BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1003098)

  • 1. Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.
    Goetzl EJ; Austen KF
    J Exp Med; 1976 Dec; 144(6):1424-37. PubMed ID: 1003098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.
    Goetzl EJ; Austen KF
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4123-7. PubMed ID: 1060093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemotactic receptor for val(ala)-gly-ser-glu on human.
    Boswell RN; Austen KF; Goetzl EJ
    Immunol Commun; 1976; 5(6):469-79. PubMed ID: 992702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human eosinophils, acidic tetrapeptides (ECF-A) and histamine. Interactions in vitro and in vivo.
    Turnbull LW; Evans DP; Kay AB
    Immunology; 1977 Jan; 32(1):57-63. PubMed ID: 403129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic activity of guinea pig eosinophils for the ECF-A acidic tetrapeptides, histamine, histamine metabolites, and the effect of H1- and H2-receptor antagonists.
    Jones DG; Kay AB
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):277-82. PubMed ID: 22498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
    Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic capabilities of HL-60 human myeloid leukemia cells differentiated to eosinophils.
    Howe RS; Fischkoff SA; Rossi RM; Lyttle CR
    Exp Hematol; 1990 May; 18(4):299-303. PubMed ID: 2323365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
    Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
    J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes.
    Immunology; 1976 Nov; 31(5):797-802. PubMed ID: 992712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.
    Anwar AR; Kay AB
    Nature; 1977 Oct; 269(5628):522-4. PubMed ID: 909604
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E; Schröder JM; Christophers E
    J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte accumulation in sparganosis: demonstration of eosinophil and neutrophil chemotactic factors from the plerocercoid of Spirometra erinacei in vivo and in vitro.
    Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
    Am J Trop Med Hyg; 1984 Jan; 33(1):138-43. PubMed ID: 6364853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil chemotactic peptide sequences in rat alpha-CGRP. Activation of a novel trophic action by neutral endopeptidase 24.11.
    Davies D; Medeiros MS; Keen J; Turner AJ; Haynes LW
    Ann N Y Acad Sci; 1992 Jun; 657():405-11. PubMed ID: 1637096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.